跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INVEGA TRINZA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
INVEGA TRINZA
Authorized
STANDARD
INVEGA TRINZA
Janssen Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ac67fff6092cba31
Company
Janssen Inc
Type
Standard
Approval Details
Approval Id
ac67fff6092cba31
Drug Approval Canada Name
INVEGA TRINZA
Product Name
INVEGA TRINZA
Status
Marketed
Status Date
2016-07-25
Original Market Date
2016-07-25
Din
02455943
Drug Class
Human
Dosage Form
Suspension (Extended-Release)
Route Of Administration
Intramuscular
Schedule
Prescription
Ahfs
28:16.08.04
Atc Original
N05AX13 PALIPERIDONE
Atc Name
n 05 ax 13
Aig Number
0152320011
Company Name
Janssen Inc
Company Address
19 Green Belt Drive, Toronto, Ontario, Canada, M3C 1L9
Company Detail Path
/organization/janssen-inc
Company Information
Pharmaceutical Company Name
Janssen Inc.
Name En
Janssen Inc.
Country Name
Canada
Province Name
Ontario
City Name
north york,ontario,country_ca
Address
19 Green Belt Dr
Active Ingredients
PALIPERIDONE (PALIPERIDONE PALMITATE)
175 MG / 0.875 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ac67fff6092cba31
Type
Standard
Back to Health Canada Approvals